closol 0,5 mg/g creme
2care4 generics aps - clobetasolpropionat - creme - 0,5 mg/g
dermovat 0,5 mg/g salve
orifarm a/s - clobetasolpropionat - salve - 0,5 mg/g
dermovat 0,5 mg/ml kutanopløsning
nordic prime aps - clobetasolpropionat - kutanopløsning - 0,5 mg/ml
infilea 500 mikrogram/g shampoo
egis pharmaceuticals plc - clobetasolpropionat - shampoo - 500 mikrogram/g
mometason "orifarm" 50 mikrogram/dosis næsespray, suspension
orifarm a/s - mometasonfuroat monohydrat - næsespray, suspension - 50 mikrogram/dosis
mometason "orion" 50 mikrogram/dosis næsespray, suspension
orion corporation - mometasonfuroat monohydrat - næsespray, suspension - 50 mikrogram/dosis
enerzair breezhaler
novartis europharm limited - indacaterol, glycopyrronium bromide, mometasone - astma - medicin for obstruktiv sygdomme, - enerzair breezhaler is indicated as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long acting beta2 agonist and a high dose of an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year.
bemrist breezhaler
novartis europharm limited - indacaterol, mometasone furoate - astma - medicin for obstruktiv sygdomme, - bemrist breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.
atectura breezhaler
novartis europharm limited - indacaterol acetate, mometasone furoate - astma - medicin for obstruktiv sygdomme, - atectura breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.
zimbus breezhaler
novartis europharm limited - glycopyrronium bromide, indacaterol (acetate), mometasone furoate - astma - medicin for obstruktiv sygdomme, - maintenance treatment of asthma in adults whose disease is not adequately controlled.